+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module



Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module



Cancer 120(13): 1975-1984



A prospective longitudinal study to profile patient-reported symptoms during radiotherapy (RT) or concurrent chemoradiotherapy (CCRT) for head and neck cancer was performed. The goals were to understand the onset and trajectory of specific symptoms and their severity, identify clusters, and facilitate symptom interventions and clinical trial design. Participants in this questionnaire-based study received RT or CCRT. They completed the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module before and weekly during treatment. Symptom scores were compared between treatment groups, and hierarchical cluster analysis was used to depict clustering of symptoms at treatment end. Variables believed to predict symptom severity were assessed using a multivariate mixed model. Among the 149 patients studied, the majority (47%) had oropharyngeal tumors, and nearly one-half received CCRT. Overall symptom severity (P < .001) and symptom interference (P < .0001) became progressively more severe and were more severe for those receiving CCRT. On multivariate analysis, baseline Eastern Cooperative Oncology Group performance status (P < .001) and receipt of CCRT (P < .04) correlated with higher symptom severity. Fatigue, drowsiness, lack of appetite, problem with mouth/throat mucus, and problem tasting food were more severe for those receiving CCRT. Both local and systemic symptom clusters were identified. The findings from this prospective longitudinal study identified a pattern of local and systemic symptoms, symptom clusters, and symptom interference that was temporally distinct and marked by increased magnitude and a shift in individual symptom rank order during the treatment course. These inform clinicians about symptom intervention needs, and are a benchmark for future symptom intervention clinical trials.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054899277

Download citation: RISBibTeXText

PMID: 24711162

DOI: 10.1002/cncr.28672


Related references

Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head and Neck 29(10): 923-931, 2007

Validation of the MD Anderson Symptom Inventory-Head-and-Neck-Filipino (MDASI-HN-F): clinical utility of symptom screening among patients with head-and-neck cancer. Bmj Supportive and Palliative Care 7(2): 140-149, 2017

The reliability and validity of the M. D. Anderson Symptom Inventory (MDASI-HN) as a measure of symptom burden in the head and neck cancer (HNC) patient population. Journal of Clinical Oncology 23(16_Suppl): 8097-8097, 2016

Linguistic Validation of the Turkish Version of the M.D. Anderson Symptom Inventory - Head and Neck Cancer Module. Balkan Medical Journal 33(3): 339-343, 2016

Linguistic validation of the Greek M.D. Anderson Symptom Inventory - Head and Neck Module. Forum of Clinical Oncology 3(1): 29-31, 2013

Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language. Journal of Pain and Symptom Management 51(6): 1055-1061, 2016

Italian version of the M.D. Anderson Symptom Inventory--Head and Neck Module: linguistic validation. Supportive Care in Cancer 23(12): 3465-3472, 2016

Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy. Oral Oncology 49(4): 360-366, 2013

PO-117: Symptom Burden and Quality of Life Analysis in Head and Neck Cancer Patients Suitable for Palliative Radiotherapy. RadioTherapy and Oncology 106: S49-S50, 2013

Validation of the Head and Neck Patient Symptom Checklist as a nutrition impact symptom assessment tool for head and neck cancer patients. Supportive Care in Cancer 21(1): 27-34, 2013

Liposarcoma of the head and neck: The University of Texas M. D. Anderson Cancer Center experience. Head and Neck 31(1): 28-36, 2009

Validation of the Chinese version of the Head and Neck Patient Symptom Checklist for measuring nutrition impact symptoms during radiotherapy in patients with head and neck cancer. Supportive Care in Cancer 27(12): 4705-4711, 2019

The Vanderbilt Head and Neck Symptom Survey Brazilian Portuguese version 2.0 (VHNSS 2.0): psychometric properties for patients with head and neck cancer who have undergone radiotherapy. Bmc Research Notes 8: 522, 2015

Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module. Head and Neck 39(10): 2048-2056, 2017

The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. International Journal of Radiation Oncology Biology Physics 72(5): 1355-1361, 2008